Management of cardiovascular risk factors in patients with metabolic syndrome

Cardiovascular and Hematological Agents in Medicinal Chemistry

Volumn 5, Issue 3, 2007, Pages 209-214

  de la Sierra, Alejandro ^a   Ruilope, Luis Miquel ^b  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Cardiovascular disease; Cardiovascular rick; Dyslipidemia; Hypertension; Metabolic syndrome; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; ANTIHYPERTENSIVE AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BILE ACID SEQUESTRANT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EZETIMIBE; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INSULIN SENSITIZING AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; NICOTINIC ACID; PLACEBO; RIMONABANT; ROSIGLITAZONE; SIBUTRAMINE; TETRAHYDROLIPSTATIN; TORCETRAPIB; TRIACYLGLYCEROL; UNINDEXED DRUG;

ABDOMINAL OBESITY; ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIET THERAPY; DISEASE ASSOCIATION; DRUG MECHANISM; DRUG MEGADOSE; DYSLIPIDEMIA; EPIDEMIC; EXERCISE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERDISCIPLINARY COMMUNICATION; LIFESTYLE MODIFICATION; LOW DRUG DOSE; METABOLIC SYNDROME X; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT CARE; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; RISK REDUCTION; SODIUM RESTRICTION; TRIACYLGLYCEROL BLOOD LEVEL;

CARDIOVASCULAR DISEASES; HUMANS; METABOLIC SYNDROME X; RISK FACTORS;

EID: 34547534718     PISSN: 18715257     EISSN: None     Source Type: Journal    
DOI: 10.2174/187152507781058690     Document Type: Review

References (59)

1. Reaven, G.M. Diabetes, 1988, 37, 1595.
2. Alberti, K.-G.; Zimmet, P.Z. Diabet. Med., 1998, 15, 539.
3. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Circulation, 2002, 106, 3143.
4. Grundy, S.M.; Brewer, H.B.; Cleeman, J.I.; Smith, S.C.; Lenfant, C. Circulation, 2004, 109, 433.
5. Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C.; Spertus, J.A.; Costa, F. Circulation, 2005, 112, 2735.
6. Rimm, E.B.; Stampfer, M.J.; Giovannucci, E.; Ascherio, A.; Spiegelman, D.; Colditz, G.A.; Willett, W.C. Am. J. Epidemiol., 1995, 141, 1117.
7. Folsom, A.R.; Kaye, S.A.; Sellers, T.A.; Hong, C.P.; Cerhan, J.R.; Potter, J.D.; Prineas, R.J. JAMA, 1993, 269, 483.
8. Jensen, M.D.; Haymond, M.W.; Rizza, R.A.; Cryer, P.E.; Miles, J.M. J. Clin. Invest., 1999, 83, 1168.
9. Petersen, K.F.; Shulman, G.I. Am. J. Cardiol., 2002, 98, 11G.
10. Kaplan, N.M. Arch. Intern. Med., 1989, 149, 1514.
11. Matsuzawa, Y. FEBS Lett., 2006, 580, 2917.
12. Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z. Lancet, 2005, 365, 1415.
13. Haffner, S.M.; Lehto, S.; Ronnemaa, T.; Pyorala, K.; Laakso, M. N. Engl. J. Med., 1998, 339, 229.
14. DECODE Study Group on behalf of the European Diabetes Epidemiology Group. Diabetes Care, 2003, 26, 688.
15. McFarlane, S.I.; Banerji; M.; Sowers, J.R. J. Clin. Endocrinol. Metab., 2001, 86, 713.
16. Vinik, A.I. Clin. Cornerstone, 2005, 7, 27.
17. Gress, T.W.; Nieto, F.J.; Shahar, E.; Wofford, M.R.; Brancati, F.L. N. Engl. J. Med., 2000, 342, 905.
18. Mancia, G.; Grassi, G.; Zanchetti, A. J. Hypertens., 2006, 24, 3.
19. Hseuh, W.A.; Anderson, P.W. Hypertension, 1992, 20, 253.
20. Ridker, P.M.; Buring, J.E.; Cook, N.P.; Rifai, N. Circulation, 2003, 107, 391.
21. Matsuzawa, Y.; Funahashi, T.; Nakamura, T. Ann. N.Y. Acad. Sci., 1999, 892, 146.
22. Balkau, B.; Charles, M.A. Diabet. Med., 1999, 15, 539.
23. Genuth, S.; Alberti, K.G.; Bennett, P.; Buse, J.; Defronzo, R.; Kahn, R.; Kitzmiller, J.; Knowler, W.C.; Lebovitz, H. Lemmark, A.; Nathan, D.; Palmer, J.; Rizza, R.; Saudek, C.; Shaw, J.; Steffes, M.; Stern, M.; Tuomilehto, J.; Zimmet, P.; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care, 2003, 26, 3160.
24. Alberti, K.G.; Zimmet, P.; Shaw, J. Diabet. Med., 2006, 23, 469.
25. Ford, E.S. Diabetes Care, 2005, 28, 1769.
26. Wilson, P.W.; D'Agostino, R.B.; Levy, D.; Belanger, A.M.; Silbershatz, H.; Kannel, W.B. Circulation, 1998, 97, 1837.
27. Lakka, H.M.; Laaksonen, D.E.; Lakka, T.A.; Niskanen, L.K.; Kumpusalo, E.; Tuomilehto, J.; Salonen, J.T. JAMA, 2002, 288, 2709.
28. Klein, S.; Burke, L.E.; Bray, G.A.; Allison, D.B.; Pi-Sunyer, X.; Hong, Y.; Eckel, R.H.; for the American Head Association Council on Nutrition, Physical Activity, and Metabolism. Circulation, 2004, 110, 2952.
29. Knowler, W.C.; Barrett-Connor, E.; Fowler, S.E.; Hamman, R.F.; Lachin, J.M.; Walker, E.A.; Nathan, D.M.; for the Diabetes Prevention Program Research Group. N. Engl. J. Med., 2002, 346, 393.
30. Katzmarzyk, P.T.; Church, T.S.; Blair, S.N. Arch. Intern. Med., 2004, 164, 1092.
31. Guidelines Committee. J. Hypertens., 2003, 21, 1011.
32. Sacks, F.M.; Svetkey, L.P.; Vollmer, W.M.; Appel, L.J.; Bray, J.A.; Harsha, D.; Obarzanek, E.; Conlin, P.R.; Miller, E.R.; Simons-Morton, D.G.; Karanja, N.; Lin, P.H.; for the DASH-Sodium Collaborative Research Group. N. Engl. J. Med., 2001, 344, 3.
33. Knoops, K.T.; de Groot, L.C.; Kromhout, D.; Perrin, A.E.; Moreiras-Varela, O.; Menotti, A.; van Staveren, W.A. JAMA, 2004, 292, 1433.
34. De la Sierra, A.; Romero, R.R.; Bonet, J.; Perez, M.; Lopez, J.S.; Ravella, R.; Aguilera, M.T. Med. Clin. (Barc.), 2006, 126, 406.
35. Elliott, W.J.; Meyer, P.M. Lancet, 2007, 369, 201.
36. Vasan, R.S.; Larson, M.G.; Leip, E.P.; Evans, J.C.; O'Donnell, C.J.; Kannel, W.B.; Levy, D. N. Engl. J. Med., 2001, 345, 1291.
37. Vasan, R.S.; Beisier, A.; Seshadri, S.; Larson, M.G.; Kannel, W.B.; D'Agostino, R.B.; Levy, D. JAMA, 2002, 287, 1003.
38. Julius, S.; Nesbitt, S.D.; Egan, B.M.;.Weber, M.A.; Michelson, E.L.; Kaciroti, N.; Black, H.R.; Grima, R.H.; Messerli, F.H.; Oparis, S.; Schork, M.A.; for the Trial of Preventing Hypertension (TROPHY) Study Investigators. N. Engl. J. Med., 2006, 354, 1685.
39. Collioun, H.M.; Betteridge, D.J.; Durrington, P.N.; Hitman, G.A.; Nel, H.A.; Livingstone, S.J.; Thomason, M.J.; Mackness, M.J.; Charlton-Menya, V.; Fuller, J.H.; for the CARDS Investigators. Lancet, 2004, 364, 685.
40. Heart Protection Study Collaborative Group. Lancet, 2002, 360; 7.
41. Ridker, P.M.; Cannon, C.P.; Morrow, D.; Rifai, N.; Rose, L.M.; McCabe, C.H.; Pfeffer, M.A.; Braunwald, E.; for the Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22) Investigators. N. Engl. J. Med., 2005, 352, 20.
42. LaRosa, J.C.; Grundy, S.M.; Waters, D.D.; Shear, C.; Barter, P.; Fruchart, J.C.; Gotto, A.M.; Greten, H.; Kastelein, J.J.; Shepherd, J.; Wenger, N.K.; for the Treating to New Targets (TNT) Investigators. N. Engl. J. Med., 2005, 352, 1425.
43. Canner, P.L.; Furberg, C.D.; McGovern, M.E. Am. J. Cardiol., 2006, 97, 477.
44. Rubins, H.B.; Robins, S.J.; Collins, D.; Nelson, D.B.; Elam, M.B.; Schaefer, E.J.; Faas, S.H.; Anderson, J.W. Arch. Intern. Med., 2002, 162, 2597.
45. Tenenbaum, A.; Motro, M.; Fisman, E.Z.; Tanne, D.; Boyko, V.; Behar, S. Arch. Intern. Med., 2005, 165, 1154.
46. The FIELD Study Investigators. Lancet, 2005, 366, 1849.
47. Chiasson, J.L.; Josse, R.G.; Gomis, R.; Hanefeld, M.; Karasik, A.; Laakso, M.; for the STOP-NIDDM Trial Research Group. Lancet, 2002, 359, 2072.
48. Knowler, W.C.; Hamman, R.F.; Edelstein, S.L.; Barrett-Connor, E.; Ehrmann, D.A.; Walker, E.A.; Fowler, S.E.; Nathan, D.M.; Kahn, S.E.; for the Diabetes Prevention Program Research Group. Diabetes, 2005, 54, 1150.
49. The DREAM (Diabetes Reduction Assessment with ramipril and rosiglitazone Medication) Trial Investigators. Lancet, 2006, 368, 1096.
50. Arterburn, D.E.; Crane, P.K.; Veenstra, D.L. Arch. Intern. Med., 2004, 164, 994.
51. Hutton, B.; Fergusson, D. Am. J. Clin. Nutr., 2004, 80, 1461.
52. Van Gaal; LF, Rissanen, A.M.; Scheen, A.J.; Ziegler, O.; Rossner, S.; for the RIO-Europe Study Group. Lancet, 2005, 365, 1389.
53. Pi-Sunyer, F.X.; Aronne, L.J.; Heshmati, H.M.; Devin, J.; Rosenstock, J.; for the RIO-North America Study Group. JAMA, 2006, 295, 761.
54. Despres, J.P.; Golay, A.; Sjostrom, L.; for the Rimonabant in Obesity-Lipids Study Group. N. Engl. J. Med., 2005, 353, 2121.
55. Scheen, A.J.; Finer, N.; Hollander, P.; Jensen, M.D.; Van Gaal, L.F.; for the RIO-Diabetes Study Group. Lancet, 2006, 368, 1660.
56. Gaede, P.; Vedel, P.; Larsen, N.; Jensen, G.V.; Parving, H.H.; Pedersen, O. N. Engl. J. Med., 2003, 348, 383.
57. Antithrombotic Trialists' Collaboration. BMJ, 2002, 324, 71.
58. Garg, R.; Tripathy, D.; Dandona, P. Curr. Drug Targets, 2003, 4, 487.
59. Lloyd-Jones, D.M.; Liu, K.; Tian, L.; Greenland, P. Ann. Intern. Med., 2006, 145, 35.